2012
DOI: 10.1016/j.vaccine.2012.04.081
|View full text |Cite
|
Sign up to set email alerts
|

A(H1N1)v2009: A controlled observational prospective cohort study on vaccine safety in pregnancy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
77
0

Year Published

2014
2014
2018
2018

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 78 publications
(79 citation statements)
references
References 21 publications
2
77
0
Order By: Relevance
“…Influenza vaccination is not associated with adverse pregnancy outcomes including fetal death, preterm birth and congenital anomalies. (12)(13)(14)(15)(16)(17) Vaccination may have reduced the risk of influenza-related fetal death during the pandemic. (12) It is essential that extensive data are available on pregnancy outcomes after gestational vaccine exposure in order to inform decisions on vaccination by pregnant women and health professionals, particularly during a pandemic situation.…”
Section: Resultsmentioning
confidence: 99%
“…Influenza vaccination is not associated with adverse pregnancy outcomes including fetal death, preterm birth and congenital anomalies. (12)(13)(14)(15)(16)(17) Vaccination may have reduced the risk of influenza-related fetal death during the pandemic. (12) It is essential that extensive data are available on pregnancy outcomes after gestational vaccine exposure in order to inform decisions on vaccination by pregnant women and health professionals, particularly during a pandemic situation.…”
Section: Resultsmentioning
confidence: 99%
“…30 Similar to seasonal influenza vaccine, no adverse birth outcomes were observed following either adjuvanted or nonadjuvanted pandemic vaccination during pregnancy in prospective or retrospective cohort studies. 28,[31][32][33][34] Several studies have suggested there is a reduction in the risk or likelihood of adverse birth outcomes following IIV during pregnancy. 20,25,35 Previous cohort studies have shown seasonal influenza vaccination during pregnancy is associated with a 40-70% reduction in preterm birth, 20,23,36 SGA birth, 20 and stillbirth.…”
Section: Inactivated Influenza Vaccinementioning
confidence: 99%
“…37,39,46 Data on fetal safety of A/H1N1pdm09 monovalent vaccines administered to pregnant women during the 2009/10 pandemic are available from the USA, 30,37 Canada, 43 Argentina, 29 Taiwan 38 and from several European countries. 10,27,31,32,36,40,41,45,48 Unadjuvanted vaccines were used in the North American studies, in France and a study in Taiwan. 30,37,38,40,43,48 The A/H1N1 MF56-adjuvanted formulation was evaluated in Argentina, Italy and the Netherlands.…”
Section: 27-49mentioning
confidence: 99%
“…10,31,36,41 In Germany and Ireland more than one vaccine formulation was commercially available and recommended for use in the pandemic campaigns. 32,45 The emergence of A/H1N1pdm09 in 2009/10 led to concurrent availability of monovalent vaccine and the seasonal influenza vaccines; with four reports from North America evaluating the birth outcomes when both type of vaccines were administered during the same pregnancy. 37,43,46,47 In the observational studies, as uptake of influenza vaccination could have been biased, adjusting for potential confounders is imperative.…”
Section: 27-49mentioning
confidence: 99%
See 1 more Smart Citation